Here we report the 3.4 Å resolution cryo-electron microscopy structure of mammalian Pol II in the form of a transcribing complex comprising DNA template and RNA transcript. We use bovine Pol II, which is identical to the human enzyme except for seven aminoacid residues. The obtained atomic model closely resembles its yeast counterpart, but also reveals unknown features. Binding of nucleic acids to the polymerase involves 'induced fit' of the mobile Pol II clamp and active centre region. DNA downstream of the transcription bubble contacts a conserved 'TPSA motif ' in the jaw domain of the Pol II subunit RPB5, an interaction that is apparently already established during transcription initiation To determine the high-resolution structure of mammalian Pol II, we prepared the bovine enzyme from calf thymus (Methods). Purified bovine Pol II contained all 12 subunits (RPB1-RPB12) in apparently stoichiometric amounts and bound to human Gdown1, an additional metazoan-specific Pol II subunit 11 (Extended Data Fig. 1a ). The polymerase also bound a synthetic DNA-RNA scaffold to form an elongation complex (EC) that was active in extending the RNA transcript (Extended Data Fig. 1b, c) . Crystallization trials were unsuccessful, but we could determine a high-resolution structure of the bovine Pol II EC by cryo-electron microscopy (cryo-EM) and single particle reconstruction (Methods).
. Upstream DNA emanates from the active centre cleft at an angle of approximately 105° with respect to downstream DNA. This position of upstream DNA allows for binding of the general transcription elongation factor DSIF (SPT4-SPT5) that we localize over the active centre cleft in a conserved position on the clamp domain of Pol II. Our results define the structure of mammalian Pol II in its functional state, indicate that previous crystallographic analysis of yeast Pol II is relevant for understanding gene transcription in all eukaryotes, and provide a starting point for a mechanistic analysis of human transcription.
To determine the high-resolution structure of mammalian Pol II, we prepared the bovine enzyme from calf thymus (Methods). Purified bovine Pol II contained all 12 subunits (RPB1-RPB12) in apparently stoichiometric amounts and bound to human Gdown1, an additional metazoan-specific Pol II subunit 11 (Extended Data Fig. 1a ). The polymerase also bound a synthetic DNA-RNA scaffold to form an elongation complex (EC) that was active in extending the RNA transcript (Extended Data Fig. 1b, c) . Crystallization trials were unsuccessful, but we could determine a high-resolution structure of the bovine Pol II EC by cryo-electron microscopy (cryo-EM) and single particle reconstruction (Methods).
The EC sample was used for cryo-EM data collection with a K2 direct electron detection device (Gatan). These data revealed particles of the expected size that resulted in defined 2D class averages (Extended Data Fig. 1d , e). Unsupervised 3D classification of 409,401 particle images led to a reconstruction of the Pol II EC from 264,134 particles at an overall resolution of 3.4 Å and a local resolution of 3.0 Å in the active centre (EC1, Extended Data Figs 2 and 3). Upstream DNA and the RPB4-RPB7 stalk were flexible, but alternative sorting of particles led to EC reconstructions with improved density for the RPB4-RPB7 stalk (EC2; 219,265 particles) and for upstream DNA (EC3; 184,122 particles) at resolutions of 3.6 Å and 3.7 Å, respectively. Density for Gdown1 was not observed in these reconstructions, probably because Gdown1 is flexibly tethered to Pol II and requires interactions with additional factors to adopt a defined location that could be detected by cryo-EM.
The vast majority of imaged particles encompassed the 12-subunit Pol II EC. A minor fraction of EC particles with a similar angular distribution displayed less density for the jaw-lobe region, indicating mobility as suggested by a previous low-resolution EM study of human Pol II 4 . An additional fraction of particles lacking nucleic acids was also observed (Extended Data Fig. 2 ). These particles contained free Pol II with a flexible clamp, also consistent with previous observations 4 . The corresponding reconstruction showed that parts of the active centre region and hybrid-binding domain were also flexible. This flexibility was only observed in the absence of nucleic acids, indicating that Pol II undergoes an induced fit when binding to nucleic acids. In the absence of nucleic acids, fork loop 2 was rearranged, covering a positively charged patch that interacts with the downstream edge of the single-stranded region of the DNA non-template strand in the EC.
The mobility of the clamp was previously inferred from crystallographic studies of yeast Pol II. Crystal structures of the ten-subunit core Pol II, lacking the Rpb4-Rpb7 stalk, trapped the clamp in two different open positions 2 , whereas binding of nucleic acids resulted in a defined, closed position of the clamp 12 that corresponded to the one observed here. The same closed position was observed in the absence of nucleic acids in crystals of the complete Pol II containing the stalk 13, 14 , although we observed here mobility of the clamp even in the presence of the stalk. In previous crystals, the stalk was involved in crystal contacts, but its conformation nevertheless matched the one seen in EM studies of yeast Pol II 15 . In the mammalian Pol II EC presented here, the stalk adopts a different orientation, which resembles that seen in a yeast EM structure of the core initiation complex bound by the core Mediator 15 . Taken together, crystallization traps Pol II conformations that exist in solution, whereas EM has the potential to unveil multiple conformations, providing insights into the conformational dynamics of the complex.
The cryo-EM density for EC1 revealed protein side chains and single nucleotides, and was comparable in quality to crystallographic maps calculated with refined model phases at a similar resolution (Fig. 1a) . We built an atomic model based on the homologous yeast Pol II structure and refined the model in real space. The resulting structure included 95% of all Pol II residues (omitting the flexible carboxy (C)-terminal domain of Pol II subunit RPB1) and showed very good stereochemistry (Extended Data Table 1 ). The structure represents one of only four asymmetric macromolecular structures with a molecular mass of around 1 MDa or less that were thus far resolved by cryo-EM at near-atomic resolution (<4 Å) [16] [17] [18] [19] . The overall structure of the mammalian Pol II EC (Fig. 1b) resembles the yeast EC crystal structures 12, 20 , but also shows differences Letter reSeArCH in surface regions of the polymerase (Extended Data Fig. 4a , b and Extended Data Table 2 ). First, mammalian Pol II exhibits an insertion in subunit RPB8 that contacts the RPB1 foot domain, which is rearranged compared with the yeast enzyme (Fig. 2a) . The Saccharomyces cerevisiae foot domain forms a transient contact with the coactivator complex Mediator 15 . It is possible that these differences affect mammalian Mediator binding. Second, mammalian Pol II contains two insertions in the region of the Pol II pore that accommodates the RNA cleavage factor TFIIS beneath the active site (Fig. 2b) . The insertion β20-β21 contains a new negatively charged helix (called here α16-2) that may interact with a positively charged region of TFIIS domain 3. The insertion in strand β32 is in a position to interact with the linker between TFIIS domains 2 and 3. This may be relevant for binding factors with TFIIS-like domains that are present in mammalian cells, but not in yeast. Third, the structure reveals that the RPB5 jaw domain is rotated by ~5° towards downstream DNA (Fig. 2c, d and Extended Data Fig. 4c) . Fourth, the EC1 map reveals nearly continuous density for the trigger loop in the active centre. The trigger loop adopts an open conformation, similar to the trapped state observed in the presence of backtracked RNA 21 and an open state observed in a recent X-ray structure of a yeast Pol II EC 22 (Extended Data Fig. 4d ). With respect to the nucleic acids, downstream DNA enters the active centre cleft and unwinds before the active site when the template strand passes over the bridge helix. The RNA transcript emanates from the active site aspartate loop and forms a hybrid with the DNA template strand. RNA separates at the upstream end of the hybrid and passes beneath the lid loop through the proposed RNA exit tunnel to reach the Pol II surface near the dock domain when it is 14 nucleotides long. Density for exiting RNA extends beyond this point, but could not be modelled owing to its increasing flexibility on the enzyme surface. The upstream DNA duplex also shows weaker density, consistent with its known mobility 20 , but adopts a defined position in the EC3 reconstruction (Fig. 3a) .
Most interactions between Pol II and the nucleic acids occur in the region of the DNA-RNA hybrid and generally involve residues that are either identical or conserved between yeast and human enzymes (Fig. 3b, c) . Density for an insertion within the RPB2 lobe (loop β9-β10) approached the downstream DNA. This loop is conserved in metazoa but not yeast, and contains two lysine residues near DNA. Further downstream, DNA contacts the Pol II jaw domain of subunit RPB5, which was moved by up to 3 Å compared with the yeast EC. The contact is made by a 'TPSA' motif comprising four conserved amino-acid residues that form the first turn of helix α6 in RPB5 (Fig. 2d) 
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promoter complex and an open complex mimic 7 , indicating that it is maintained during the transition from initiation to elongation (Extended Data Fig. 4e ). These observations are consistent with the model that downstream DNA is moved into the Pol II cleft by a translocation along RPB5 upon TFIIH action and DNA opening 7, 23 . Studies of ten-subunit yeast Pol II have revealed a similar contact with downstream DNA 22, 24 . The orientation of upstream DNA with Pol II deviates from previous observations made in the yeast system. Upstream DNA emanates from the Pol II cleft between the clamp and protrusion domains at an angle of ~105° with respect to downstream DNA, compared with the previously described ~90° on the basis of fluorescence resonance energy transfer measurements 25 and ~130° on the basis of a recent X-ray structure of a 10-subunit yeast Pol II with a larger, 15-nucleotide DNA mismatch bubble 22 . The deviation in the angle of the upstream DNA could be a result of the larger mismatch region, the redistribution of positive charges on the protrusion between yeast and mammals, or an altered conformation of loop β28-β29 on the RPB2 wall domain that approaches the minor groove of upstream DNA.
The observed position of upstream DNA is compatible with binding of the elongation factor DSIF (SPT4-SPT5) to the clamp as modelled on the basis of the archaeal and yeast complexes, whereas the previous position of upstream DNA clashed with DSIF [26] [27] [28] . To test our model, we prepared an EC with bound DSIF and determined the location of DSIF with the use of negative stain EM and crosslinking coupled to mass spectrometry. As predicted, SPT4 and the NusG amino (N)-terminal (NGN) domain of SPT5 occupied the top of the cleft, bridging between the clamp on one side and the lobe and protrusion on the other side of Pol II ( Fig. 4 and Supplementary Table 1) . Modelling on the basis of the previous X-ray structure of an archaeal clamp complex with SPT4-SPT5 places positively charged regions of the SPT5 NGN domain in close proximity to the observed position of upstream DNA and non-template DNA (Extended Data Fig. 5 ), consistent with a role of this conserved family of elongation factors in stabilizing the upstream edge of the transcription bubble 29, 30 . In summary, high-resolution structural analysis of a mammalian Pol II has become possible owing to advances in cryo-EM with the use of crystallization-grade preparations of the enzyme that have been available for years but never produced diffraction-quality crystals. The cryo-EM density map for the mammalian Pol II EC resembles in quality and resolution the best crystallographic maps obtained for the corresponding yeast complex. Comparison of the mammalian cryo-EM structure with the yeast X-ray structures reveals differences between these highly similar enzymes and provides insights into the conformational control of enzyme function. Most importantly, this work provides the basis for future structure determination of mammalian Pol II transcription complexes with mammalian-specific factors. 
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No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Purification of bovine Pol II. Bovine Pol II was prepared as described 11 with modifications. Unless otherwise noted, all steps were completed at 4 °C. Protease inhibitors included 1 mM PMSF, 1 mM benzamidine, 60 μM leupeptin, and 200 μM pepstatin. Calf thymus was homogenized for 3 min in buffer A (50 mM Tris, pH 7.9 at 4 °C, 1 mM EDTA, 10 μM ZnCl 2 , 10% glycerol, 1 mM DTT, protease inhibitors) using a 2 l blender (Waring). The homogenized material was centrifuged and the supernatant filtered through two layers of Miracloth. A 5% solution of poly ethyleneimine, pH 7.9 at 25 °C, was added to a final concentration of 0.02%, and the material was stirred for 10 min then centrifuged. The resulting pellets were washed with buffer A before resuspension in buffer A (0.15 M ammonium sulfate). After centrifugation, the conductivity of the supernatant was adjusted to that of buffer A (0.2 M ammonium sulfate), and the resulting material was loaded on a 225-ml MacroPrepQ column equilibrated in buffer A (0.2 M ammonium sulfate). The column was washed with two column volumes of buffer A (0.2 M ammonium sulfate), followed by Pol II elution with buffer A (0.4 M ammonium sulfate). The eluate was precipitated by addition of finely ground ammonium sulfate added to 50% saturation, and pellets were collected by centrifugation. The pellets were resuspended in buffer A, and the conductivity was adjusted to that of buffer A (0.15 M ammonium sulfate). The material was clarified by centrifugation, and further purified using a 5-ml gravity flow column of 8WG16 (αRPB1 CTD) antibody-coupled sepharose equilibrated in buffer A (0.15 M ammonium sulfate). After application of the input material, the antibody column was washed with five column volumes of buffer A (0.5 M ammonium sulfate), sealed, and allowed to equilibrate to room temperature (20-25 °C) for 15 min. Pol II was eluted using buffer A (0.5 M ammonium sulfate, 50% (v/v) glycerol), and Pol-II-containing fractions were immediately mixed with buffer A (2 mM DTT, lacking glycerol and protease inhibitors). The diluted material was centrifuged and subjected to anion exchange chromatography using a UNO-Q column equilibrated in buffer A (0.1 M ammonium sulfate, 2 mM DTT, lacking protease inhibitors). Pol II was eluted using a linear gradient from 0.1 M to 0.5 M ammonium sulfate in buffer A (2 mM DTT, lacking protease inhibitors). For the purification of 12-subunit bovine Pol II, the Gdown1-free Pol II fraction was applied to a Sephacryl S-300 HiLoad sizing column equilibrated in buffer B (150 mM NaCl, 5 mM HEPES pH 7.25 at 25 °C, 10 μM ZnCl 2 , 10 mM DTT). For the purification of bovine Pol II containing Gdown1, the Gdown1-free Pol II fraction was incubated with a 3× molar excess of human Gdown1 for 1 h at 4 °C before application to the Sephacryl S-300 HiLoad sizing column. Pol-II-containing fractions were concentrated using a 100-kDa cutoff Amicon concentrator to a final concentration of 2-4 mg ml −1 . Preparation of recombinant human proteins. Gene-optimized human Gdown1 (Life Technologies) was cloned into pOPINB (N-terminal His 6 tag and 3C protease site). After transformation, Escherichia coli BL21(DE3)RIL cells were grown at 37 °C in Lysogeny broth (LB) medium to an absorbance at 600 nm, A 600 nm , of 0.5 before protein expression with 0.5 mM IPTG for 3-4 h at 37 °C. Subsequent steps were completed at 4 °C unless otherwise noted. Cells were lysed by sonication in buffer C (50 mM HEPES pH 7.5 (25 °C), 300 mM NaCl, 1 mM CaCl 2 , 10% glycerol) supplemented with 10 mM imidazole, 1 mM PMSF, 1 mM benzamidine, 1 mM sodium metabisulfite, 1 mM DTT, and 2 μg ml −1 DNase I. Cleared lysate was subjected to affinity chromatography using Ni-NTA agarose (Qiagen), and excess chaperone was removed by washing the resin with a 5 mM ATP and 2 mg ml −1 denatured E. coli protein wash at room temperature in buffer C supplemented as above containing 30 mM imizdazole. Protein was eluted with buffer C supplemented as above, but lacking DNase I and containing 250 mM imidazole. Elutions were exchanged into buffer C supplemented with 10 mM imidazole and 1 mM DTT via a PD10 desalting column, followed by 3C protease cleavage at 4 °C overnight. Cleaved Gdown1 was subjected to reverse chromatography (Ni-NTA agarose) followed by dilution with buffer D (50 mM HEPES pH 7.5 (25 °C), 1 mM CaCl 2 , 10% glycerol, 2 mM DTT) to a conductivity of buffer D containing 0.05 M NaCl. Diluted protein was subjected to cation exchange chromatography (MonoS 5/50) to remove additional chaperone, and eluted with a linear gradient from 0.05 M to 0.5 M NaCl in buffer D. The conductivity of the Gdown1-containing fractions was again adjusted to that of buffer D containing 0.05 M NaCl, and applied to a MonoQ 5/50 anion exchange column. Gdown1 was eluted using a linear gradient from 0.05 M to 0.5 M NaCl in buffer D. Fractions containing purified Gdown1 were pooled, resulting in a final concentration of 1-1.5 mg ml −1
. Yield was approximately 2.5 mg per 2 l of E. coli culture.
Purification of human SPT4 and SPT5 was as described 31 , with adaptations. Gene-optimized human SPT5 (pMK vector, no tag) and SPT4 were purchased from Life Technologies, and SPT4 was recloned into pOPINJ (N-terminal HIS6 and GST tags followed by a 3C protease cleavage site). SPT4 and SPT5 vectors were co-transformed into E. coli BL21(DE3)RIL cells, which were then grown at 37 °C in LB medium supplemented with 10 μM ZnCl 2 to A 600 nm = 0.6. Expression was induced with 1 mM IPTG for 18 h at 18 °C. Cells were lysed by sonication in buffer E (25 mM Tris pH 7.4 (4 °C), 500 mM NaCl, 10 μM ZnCl 2 , 5 mM DTT) supplemented with 5 mM imidazole and protease inhibitors (1 mM PMSF, 1 mM benzamidine, 60 μM leupeptin, and 200 μM pepstatin). Soluble material was passed over a Ni-NTA agarose column and washed with ten column volumes each of buffer E supplemented with 20 mM or 40 mM imidazole before elution in buffer E supplemented with 300 mM imidazole. Eluted protein was cleaved with 3C protease during overnight dialysis (4 °C) against buffer E, then subjected to reverse chromatography. Protein was passed over a HiTrap Q HP anion exchange column to remove DNA, and the flow-through fraction containing SPT4/5 was concentrated using a 50-kDa cutoff Amicon concentrator to 1-4 mg ml 5× molar excess of pre-annealed template DNA (sequence 5′-AAGCTCAAGTACTTAAGCCTGGTCATTACTAGTACTGCC-3′), nontemplate DNA (sequence 5′-GGCAGTACTAGTAAACTAGTATTGAAAGTA CTTGAGCTT-3′), and RNA (sequence 5′-UAUAUGCAUAAAGACCAGGC-3′) were incubated with Pol II-Gdown1 at 4 °C for 10 min, then 20 °C for 15 min. To increase the randomness of Pol II EC particle orientations, the resulting complex (0.85 μM) was crosslinked with 3 mM BS3 (Thermo) for 30 min at 30 °C, then quenched with 50 mM ammonium bicarbonate. Crosslinked complex was applied to a Superdex 200 increase 10/300 GL column equilibrated in buffer B (150 mM NaCl, 5 mM HEPES pH 7.25 at 25 °C, 10 μM ZnCl 2 , 10 mM DTT). The nucleic-acidcontaining peak was concentrated to ~0.3 mg ml −1 as described above and used immediately for cryo-EM grid preparation. Electron microscopy. Four microlitres of sample were applied to glow-discharged Quantifoil R 3.5/1 holey carbon grids, which were then blotted and plunge-frozen in liquid ethane using a Vitrobot (FEI). Data were acquired using an FEI Titan Krios operated in energy-filtered transmission electron microscopy (EFTEM) mode at 300 kV equipped with a Gatan K2 Summit direct detector. Automated data collection was performed using the TOM toolbox 32 . Movie images were collected at a nominal magnification of ×37,000 (1.35 Å per pixel) in 'super-resolution mode' (0.675 Å per pixel) at a dose rate of about nine electrons per pixel per second. Two movies were acquired per hole, and each movie encompassed a total dose of ~43 electrons per square ångström over 8 s fractionated into 40 frames (0.2 s each). Defocus values ranged from −0.6 μm to −3.1 μm. Movies were aligned and binned as previously described 15, 33 , except that images were not partitioned into quadrants. Unless otherwise noted, processing was performed using RELION 1.3 (ref. 34 ). Contrast transfer function (CTF) parameters were estimated using CTFFIND4 (ref. 35) . Initial 2D classes were generated after semi-automated picking of ~10,000 particles (box size 204) using e2boxer.py (EMAN2) 36 . Sixteen distinct classes were low-pass filtered to 25 Å resolution and used as templates for autopicking 37 , resulting in 476,100 particles selected from 1,172 micrographs. The autopicked particles were subjected to manual screening followed by screening by 2D classification, yielding an input data set of 409,401 particles. A previously published 22-Å-resolution cryo-negative stain reconstruction of human Pol II (EMD-1282) 4 filtered to 50 Å was used as an initial reference for 3D refinement. Before any 3D classification, data were subjected to the particle polishing movie-processing algorithm of RELION 1.3 (ref. 38) , resulting in an improvement in resolution from 3.7 Å to 3.4 Å.
Three-dimensional classification was performed without image alignment as outlined in Extended Data Fig. 2 . Masks were chosen to include either the entire Pol II EC or a smaller region of interest. The full data set was used as input for the classification of heterogeneity in the region of upstream DNA density. Only classes displaying strong clamp density were used as input for classification of conformations of the RPB4-RPB7 stalk. After classification, data were again subjected to 3D refinement with a 50 Å filtered reference volume. B-factors were automatically estimated in RELION 39 and resolutions were reported on the basis of the gold-standard Fourier shell correlation (FSC) (0.143 criterion) 40 as described 41 . The Pol II EC1 reconstruction was calculated from 264,134 particles to 3.4 Å resolution and sharpened with a B-factor of −137 Å 2 . The Pol II EC2 (improved RPB4-RPB7 stalk density) reconstruction was calculated from 219,265 particles to 3.6 Å and sharpened with a B-factor of −128 Å 2 . The Pol II EC3 (improved upstream DNA density) reconstruction was calculated from 184,122 particles to 3.7 Å and sharpened with a B-factor of −123 Å 2 . Focused refinements were achieved by continuing a refinement of the full data set from the iteration at which local searches began, but replacing the mask encompassing the entire Pol II EC density with a soft mask around the region of interest and allowing the refinement to continue to convergence. Local resolution was Letter reSeArCH calculated using a sliding window method as described 15, 42 , except that a single pair of half maps was used per estimation and local resolution was not capped at the nominal value. Figures were generated using UCSF Chimera 43 .
Model building and refinement. Alignments for each Pol II subunit were generated using the Homo sapiens, Bos taurus, Drosophila melanogaster, Schizosaccharomyces pombe, and S. cerevisiae sequences followed by alignment using Clustal Omega 44 . The Pol II crystal structure PDB 4BBS 45 was chosen as a reference, as it displayed good stereochemistry and included the most complete model of the RPB2 protrusion domain. A starting model of ten-subunit Pol II was generated using the CCP4 (ref. 46) program chainsaw 47 along with the alignment of the B. taurus and S. cerevisiae sequences. Conserved amino acids were retained, and non-conserved amino acids were pruned back to the gamma atom. The starting model was placed in the Pol II EC density by fitting in UCSF Chimera 43 , followed by fitting of rigid body groups in COOT 48 . Groups for rigid body refinement were chosen on the basis of observations from Pol II X-ray studies and visual inspection of the initial fit to the density. In regions of sufficient density quality, the model was manually adjusted to include complete side chains, and missing or divergent regions were built in COOT using B-factor sharpened maps. Multiple maps were used during model building, including the densities for the refinement using all data, Pol II EC1, Pol II EC2, Pol II EC3, and focused refinements.
To generate a complete EC model, one molecule (chains A and B) of the crystal structure of human RPB4-RPB7 (PDB 2C35) 49 was docked into the Pol II EC2 map. Regions near the ten-subunit core were adjusted manually to fit the density. Amino-acid side chains (previously stubbed) were added to the model if side chain density was visible. Ideal B-form DNA was manually fitted into the Pol II EC3 upstream DNA density. To improve backbone geometry, the EC model was subjected to PHENIX real space refinement (global minimization and ADP refinement) into one of the three unsharpened EC maps using Ramachandran, rotamer, and nucleic-acid restraints 50 . EC3 was used for refinement of the upstream DNA (chain N residues 1-13 and chain T residues 27-39). Because of the lower local resolution of the distal end of the upstream DNA, residues 1-10 of the non-template strand and residues 29-39 of the template strand were replaced with ideal B-form DNA that had been aligned to the refined upstream nucleic acids. EC2 was used for refinement of RPB4 and RPB7, and EC1 was used for the remaining model (EC body). The EC body was additionally refined as described above using the sharpened EC1 map to better position well-resolved side chains and nucleic acids within the density 50 . The final model was validated using Molprobity 51 , EMRinger 52 , and the FSC of the final model versus the EC1 map (Extended Data Fig. 3b) . For model versus map FSC calculations, the EC1 map was masked using the RELIONgenerated soft automask used in postprocessing. Crosslinking and mass spectrometry. Nucleic-acid scaffold used to assemble Pol II EC complexes was modified to include a 50 nucleotide RNA (sequence 5′-G AA CG AG AU CA UA AC AU UU GA AC AA GA AU AU AU AU ACAUAAAGACCA GGC-3′), as previous data have shown that DSIF affinity for ECs is increased as RNA length increases 53 . RNA was produced and purified as previously described 54 . A twofold molar excess of pre-annealed RNA and template DNA was incubated with Pol II for 20 min at 25 °C, followed by incubation with fourfold excess of nontemplate DNA for an additional 20 min at 25 °C. A fivefold molar excess of DSIF was incubated with the resulting Pol II EC for 20 min at 25 °C. Pol II-DSIF EC sample was applied to two consecutive Superdex 200 10/300 size-exclusion columns equilibrated in buffer B (150 mM NaCl, 5 mM HEPES pH 7.25 at 25 °C, 10 μM ZnCl 2 , 10 mM DTT). Purified Pol II-DSIF EC was concentrated to ~0.5 mg ml −1 (~0.74 μM) and crosslinked with 3 mM BS3 (BS3-d0/d12, Creative Molecules) as described above. Crosslinked sample was again applied to two Superdex 200 10/300 columns, resulting in ~ 25 μg material. Sample was digested with trypsin, and analysed as previously described 15, 55 . Negative stain electron microscopy of the Pol II-DSIF EC. Pol II-DSIF EC complexes were prepared as described above. Sample (~30 μg ml ) was applied to glow-discharged 400 mesh copper grids coated with continuous carbon (Plano EM) for 1 min, washed on 500 μl water for 30 s, floated for 20 s on three consecutive 20-μl drops of 2% uranyl formate stain, and blotted to remove excess stain. Data were collected using an FEI Tecnai Spirit operated at 120 kV and a magnification of ×90,600. Micrographs were collected using a defocus range from −1.0 to −1.5 μm with an FEI Eagle CCD (charge-coupled device) camera binned 2× (image dimensions 2,048 pixels × 2,048 pixels) at a pixel size of 3.31 Å. Semiautomatic picking using e2boxer.py (EMAN2) yielded 11,531 particles from 120 micrographs. Data were subjected to 3D classification in RELION (eight classes, no CTF correction) using the cryo-negative stain reconstruction of human Pol II (EMD-1282) 4 l o w -p ass f i l t e red t o 6 0 Å a s a n i n i ti al r e f er e n ce. T h e t w o h i g he st p o p ul ated c l a ss es (comprising 85% of the data) were further classified into two classes each, for a total of four classes in which Pol II features beyond 60 Å were recognizable. Two classes did not have discernible additional density compared with Pol II (42% of data). A third class (28% of the data) displayed additional density near the RPB4-RPB7 stalk. A final class (15% of the data) showed additional density over the Pol II DNA binding cleft, as well as additional density near the RPB4-RPB7 stalk. Refinement of this subset of data (1,630 particles) resulted in a 3D reconstruction at 26 Å resolution, revealing extra density consistent with results from crosslinking coupled to mass spectrometry, previous DSIF-RNA crosslinking 56 , and the published interaction between SPT5 and the Pol II clamp coiled-coil motif 26 . Transcription assays. Activity assays were performed as described 57 , with modifications. For reactions using fully complementary template and non-template DNA sequences, Pol II ECs were assembled stepwise beginning with either 12-subunit bovine Pol II or 12-subunit bovine Pol II in complex with human Gdown1, as indicated. Per reaction, Pol II was pre-assembled for 20 min at 28 °C with a 0.5 molar ratio of 5′ 6-FAM-labelled 20-nucleotide RNA annealed to template DNA, followed by incubation with a 1.0 molar ratio of fully complementary nontemplate DNA. The RNA and DNA sequences were the same as for the Pol II EC, except for an additional 46 nucleotides of downstream DNA. The template DNA sequence was 5′-ACAAATTACTGGGAAGTCGACTATGCAATACAGGCAT CATTTGATCAAGCTCAAGTACTTAAGCCTGGTCATTACTAGTACTGCC-3′; the non-template DNA sequence was 5′-GGCAGTACTAGTAATGACCAGG CTTAAGTACTTGAGCTTGATCAAATGATGCCTGTATTGCATAGTCGACT TCCCAGTAATTTGT-3′, and RNA sequence was 5′-UAUAUGCAUAAAGA CCAGGC-3′. Transcription was allowed to proceed for 10 min at 30 °C in the presence of 1-100 μM nucleoside triphosphates (NTPs) as indicated, and 0.2 pmol product per reaction was visualized on a 15% denaturing urea polyacrylamide gel. Transcription assays were also performed on the bubble scaffold used for structural studies. Pol II-EC complexes were prepared as described for cryo-EM, except that the samples were not crosslinked and the 20-nucleotide RNA used for assembly was 5′-labelled with 6-FAM. Assembled complex was incubated with 10-1,000 μM UTP at 30 °C for 10 min, allowing the extension of the RNA by two additional nucleotides. Product was visualized on a 20% denaturing urea polyacrylamide gel and imaged using a Typhoon FLA 9500. 
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